CMVp-HHRibo-gRNA1-HDVRibo-pA vector (V010035)

Basic Vector Information

Vector Name:
CMVp-HHRibo-gRNA1-HDVRibo-pA
Antibiotic Resistance:
Ampicillin
Length:
3928 bp
Type:
Cloning vector
Replication origin:
ori
Source/Author:
Nissim L, Perli SD, Fridkin A, Perez-Pinera P, Lu TK.

CMVp-HHRibo-gRNA1-HDVRibo-pA vector Vector Map

CMVp-HHRibo-gRNA1-HDVRibo-pA3928 bp60012001800240030003600AmpR promoterf1 oriCMV enhancerCMV promoterhammerhead ribozymegRNA scaffoldHDV ribozymeHSV TK poly(A) signaloriAmpR

CMVp-HHRibo-gRNA1-HDVRibo-pA vector Sequence

Copy Sequence

Download GeneBank File(.gb)

LOCUS       40924_505        3928 bp DNA     circular SYN 17-DEC-2018
DEFINITION  Cloning vector CMVp-HHRibo-gRNA1-HDVRibo-pA, complete sequence.
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 3928)
  AUTHORS   Nissim L, Perli SD, Fridkin A, Perez-Pinera P, Lu TK.
  TITLE     Multiplexed and programmable regulation of gene networks with an 
            integrated RNA and CRISPR/Cas toolkit in human cells
  JOURNAL   Mol. Cell 54 (4), 698-710 (2014)
  PUBMED    24837679
REFERENCE   2  (bases 1 to 3928)
  AUTHORS   Perli SD.
  TITLE     Direct Submission
  JOURNAL   Submitted (04-MAY-2014) Electrical Engineering and Computer Science,
            Massachusetts Institute of Technology, 77, Massachusetts Avenue, 
            Cambridge, MA 02139, USA
REFERENCE   3  (bases 1 to 3928)
  TITLE     Direct Submission
REFERENCE   4  (bases 1 to 3928)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Mol. Cell";
            date: "2014"; volume: "54"; issue: "4"; pages: "698-710"
COMMENT     SGRef: number: 2; type: "Journal Article"; journalName: "Submitted 
            (04-MAY-2014) Electrical Engineering and Computer Science, 
            Massachusetts Institute of Technology, 77, Massachusetts Avenue, 
            Cambridge, MA 02139, USA"
COMMENT     SGRef: number: 3; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..3928
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     promoter        complement(620..724)
                     /label=AmpR promoter
     rep_origin      751..1206
                     /label=f1 ori
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"
     enhancer        1395..1698
                     /label=CMV enhancer
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        1699..1902
                     /label=CMV promoter
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     ncRNA           1936..1972
                     /label=hammerhead ribozyme
     misc_RNA        1993..2068
                     /label=gRNA scaffold
                     /note="guide RNA scaffold for the Streptococcus pyogenes 
                     CRISPR/Cas9 system"
     ncRNA           2073..2140
                     /label=HDV ribozyme
     polyA_signal    2389..2436
                     /label=HSV TK poly(A) signal
                     /note="herpes simplex virus thymidine kinase
                     polyadenylation signal (Cole and Stacy, 1985)"
     rep_origin      complement(2928..3516)
                     /direction=LEFT
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"
     CDS             complement(join(3690..3928,1..619))
                     /codon_start=1
                     /label=AmpR
                     /note="beta-lactamase"
                     /translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYI
                     ELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYS
                     PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW
                     EPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSA
                     LPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS
                     LIKHW"

This page is informational only.